About FHH
History
Organizational structure
- Standing Committee
- Sub-Committee
Ex-Chairperson
Members List
Photos
Bulletin Board
Information
Notice
Short Communications
Adulterated Herbal Medicine
- Purpose
- Database
Herbs World Wide
Meetings
Standing Committee
International Symposium
Meeting Materials
Sub-Committee 1
Sub-Committee 2
Sub-Committee 3
FHH Previous Meeting
Projects
Pharmacopoeia
- Purpose
- Products
- Terminology
- Link
FHH Atlas
FHH RMPM
- Purpose
- Results
- Distribution
COVID-19
COVID-19
Link
Link
Sign In
About FHH
History
Organizational structure
Ex-Chairperson
Members List
Photos
History
History
Organizational structure
Ex-Chairperson
Members List
Photos
Meetings
게시물 검색폼
Keyword
ADR
Adulteration
Aflatoxin
Benzopyrene
CITES
Collaboration
DNA
Efficacy
GA(C)P
GMP
Guideline
Heavy metal
Microorganism
Pesticide
Pharmacopoeia
Processing
Quality
Reference substance
Regulation
Registration
Safety
Sulfur dioxide
Surveillance
Training
Year
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
[Total :
709
]
No.
Code
Title
Speaker
Country
412
14th FSC 10 (2016)
Case report on research and development of herbal extractives reference substance
Lina LIU
China
411
14th FSC 09 (2016)
Case report on research and development of herbal materials reference substance(HMRS)
Kunzi YU
China
410
14th FSC 08 (2016)
Comparative studies on Japanese pharmacopoeia (JP17) and Chinese pharmacopoeia (CP2010)
Noriaki KAWANO_Nobou KAWAHARA
Japan
409
14th FSC 07 (2016)
New progress in the registration of TCMs in 2016
WANG Hainan
China
408
14th FSC 06 (2016)
Chinese medicines in Hong Kong - Regulatory regime and latest development
Kwok Wai LAW
Hong Kong SAR, China
407
14th FSC 05 (2016)
Pharmaceutical quality control approach of herbal medicine & The latest technical specification
HA Minh Hien
Vietnam
406
14th FSC 04 (2016)
Regulation of complementary health products in Singapore
Qian ZHANG
Singapore
405
14th FSC 03 (2016)
Stability test for reference materials of natural products
Il Hyun KANG
Republic of Korea
404
14th FSC 02 (2016)
Topics in the revision of Japanese pharmacopoeia 17th edition
Takashi HAKAMATSUKA
Japan
28
29
30
31
32
33
34
35
36